FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

37538611000001103: Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Sep 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
365851000001119 Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
365861000001116 Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Is a Dapagliflozin 5mg / Metformin 1g tablets 56 tablet true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Has AMP Xigduo 5mg/1000mg tablets (CST Pharma Ltd) true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Has specific active ingredient Dapagliflozin propanediol monohydrate false Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dapagliflozin false Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (CST Pharma Ltd) 56 tablet Has specific active ingredient Dapagliflozin propanediol monohydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start